Tozaro is a biotech company leveraging molecular modelling and machine learning (ML) to design and develop stable and cost-effective polymers that bind to gene therapy vectors specifically & selectively. The Smart Polymer™ platform utilises >500 chemical groups to develop specific binding compounds, compared to traditional technologies using proteins and peptides, which use ca. 20 amino acids. Tozaro is able to mine a huge new chemical space using cost-effective Smart Polymers™
Tozaro: Venture Capital Funding History
Tozaro
- Health
- Bedfordshire, United Kingdom
- £6m
- tozaro.com
- Update Information
More venture news
- 16 Nov 2026

ZyaZya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
Series AHealth - 4 Nov 2026

SurghiveSurghive raises a £320k seed round led by SFC Capital to train surgeons on any robotic surgery system
SeedHealth - 3 Nov 2026

1nhaler1nhaler lands a £2m follow-on round led by Archangels to test its pop-up cardboard asthma inhaler in patients
Follow-onHealth
